13F Filings History of CHI Advisors LLC

Latest 13F report
Q3 2023 - 13 Nov 2023
Value $
$238,059,062
Signature - Title
Ashley Latourelle - Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by CHI Advisors LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. CHI Advisors LLC reported 26 stock holdings with total value $238,059,062 as of Q3 2023. Top holdings included PLRX, RPTX, CGEM, SLRN, and LRMR.

Notify me when CHI Advisors LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2023 26 $238,059,062 +$24,903,324 -$62,046,889 -$37,143,565 PLRX, RPTX, CGEM, SLRN, LRMR 13F-HR 13 Nov 2023, 17:03
Q2 2023 25 $329,400,802 +$88,150,511 -$159,153,213 -$71,002,702 PLRX, SLRN, VECT, CGEM, RPTX Restatement 21 Aug 2023, 20:53
Q1 2023 23 $376,592,057 +$21,157,020 -$23,831,427 -$2,674,407 RXDX, PLRX, VECT, CGEM, RPTX 13F-HR 11 May 2023, 16:13
Q4 2022 22 $375,432,407 +$19,421,257 -$99,292,174 -$79,870,917 RXDX, PLRX, VECT, RPTX, CGEM 13F-HR 13 Feb 2023, 09:28
Q3 2022 25 $371,907,000 +$37,564,338 -$20,200,956 +$17,363,382 RXDX, PLRX, CGEM, RPTX, VECT 13F-HR 09 Nov 2022, 12:59
Q2 2022 25 $251,754,000 +$43,291,182 -$63,001 +$43,228,181 RXDX, CGEM, RPTX, PLRX, VECT 13F-HR 12 Aug 2022, 16:01
Q1 2022 21 $234,959,000 +$37,229,525 -$7,390,379 +$29,839,146 RXDX, RPTX, CGEM, PLRX, VECT 13F-HR 16 May 2022, 15:06
Q4 2021 20 $301,278,000 +$33,364,723 -$44,989,921 -$11,625,198 RXDX, RPTX, CGEM, PLRX, LRMR 13F-HR 11 Feb 2022, 11:42
Q3 2021 19 $342,586,000 +$22,610,368 -$21,903,222 +$707,146 RXDX, RPTX, CGEM, PLRX, VECT 13F-HR 15 Nov 2021, 13:16
Q2 2021 18 $429,870,000 +$32,686,532 -$16,133,349 +$16,553,183 RPTX, RXDX, PLRX, CGEM, VECT 13F-HR 11 Aug 2021, 16:59
Q1 2021 21 $499,513,000 +$178,667,675 -$16,495,319 +$162,172,356 CGEM, PLRX, RPTX, RXDX, ORTX 13F-HR 14 May 2021, 09:42
Q4 2020 20 $354,926,000 +$56,359,316 -$14,827,269 +$41,532,047 RPTX, ONCR, PLRX, LRMR, KROS 13F-HR 12 Feb 2021, 15:43
Q3 2020 21 $281,078,000 +$58,918,252 -$7,666,645 +$51,251,607 RPTX, PLRX, INZY, LRMR, KROS 13F-HR 12 Nov 2020, 15:01
Q2 2020 19 $256,252,000 +$217,014,266 -$13,071,053 +$203,943,213 RPTX, PLRX, AKUS, KROS, LRMR Restatement 17 Aug 2020, 11:23
Q1 2020 13 $42,434,000 +$3,188,131 -$73,032,624 -$69,844,493 ORTX, DTIL, LVGO, OVID, BPMC 13F-HR 14 May 2020, 15:36
Q4 2019 12 $132,570,000 +$1,877,063 -$6,221,379 -$4,344,316 LVGO, ORTX, DTIL, OVID, BPMC 13F-HR 14 Feb 2020, 15:55
Q3 2019 13 $102,720,000 $0 $0 $0 LVGO, ORTX, DTIL, OVID, GBT 13F-HR 12 Nov 2019, 13:21